Denali Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Denali Therapeutics

07/11/2024 04:28

* Denali Therapeutics Inc  DNLI.OQ  reported a quarterly
adjusted
loss of 63 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -72 cents.  The mean expectation of
sixteen analysts for the quarter was for a loss of 61 cents per
share. Wall Street expected results to range from -74 cents
to -45 cents per share.
    * Reported revenue was zero​; analysts expected $9.00
million. 
    * Denali Therapeutics Inc's reported EPS for the quarter was
a
loss of 63 cents​.
    * The company reported a quarterly loss of $107.19 million.
    * Denali Therapeutics Inc shares had fallen by 5.1% this
quarter and gained 28.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Denali
Therapeutics Inc is $40.00 
This summary was machine generated from LSEG data November 7 at
04:27 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.61          -0.63          Missed
 Jun. 30 2024      -0.69          -0.59          Beat
 Mar. 31 2024      -0.70          -0.78          Missed
 Dec. 31 2023      -0.80          -0.86          Missed